2IA Stock Overview
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
iAnthus Capital Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.024 |
| 52 Week Low | CA$0.0005 |
| Beta | 0.67 |
| 11 Month Change | -92.31% |
| 3 Month Change | -90.91% |
| 1 Year Change | -75.00% |
| 33 Year Change | -99.61% |
| 5 Year Change | -99.96% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2IA | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -92.3% | -1.2% | -0.02% |
| 1Y | -75.0% | -20.1% | 8.2% |
Return vs Industry: 2IA underperformed the German Pharmaceuticals industry which returned -20.1% over the past year.
Return vs Market: 2IA underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| 2IA volatility | |
|---|---|
| 2IA Average Weekly Movement | 638.5% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 2IA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2IA's weekly volatility has increased from 340% to 638% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 760 | Richie Proud | www.ianthus.com |
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products.
iAnthus Capital Holdings, Inc. Fundamentals Summary
| 2IA fundamental statistics | |
|---|---|
| Market cap | €45.85m |
| Earnings (TTM) | -€51.98m |
| Revenue (TTM) | €158.38m |
0.3x
P/S Ratio-0.9x
P/E RatioIs 2IA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2IA income statement (TTM) | |
|---|---|
| Revenue | US$164.93m |
| Cost of Revenue | US$93.03m |
| Gross Profit | US$71.89m |
| Other Expenses | US$126.02m |
| Earnings | -US$54.12m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0081 |
| Gross Margin | 43.59% |
| Net Profit Margin | -32.82% |
| Debt/Equity Ratio | -189.6% |
How did 2IA perform over the long term?
See historical performance and comparison